ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions
The ADA unveils the association's first Standards of Care for Overweight and Obesity, with a chapter on weight stigma and bias one of the first released.
The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment
Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.
Dual GLP-1/GLP-2 Agonist Dapiglutide Achieves 11.6% Mean Weight Loss at 28 Weeks in Phase 1b Trial
The investigational dual GLP-1/GLP-2 agonist led to 11.6% weight loss over 28 weeks with no lifestyle changes, showing strong safety and tolerability in the trial.
The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship
Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.
Teledermatology-Dermoscopy Program Could Help Reduce Inequities in Skin Cancer Screening
A student-led teledermatology initiative that identified skin lesions in underserved communities could be a scalable model for early skin cancer detection and care.
Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision
The only pre-exposure prophylaxis approved for twice-a-year dosing, lenacapavir "could be the transformative PrEP option we’ve been waiting for," one expert said.
